LB Pharmaceuticals Sets R&D Day for October 27, 2026
LB Pharmaceuticals Inc. announced it will host an in-person and virtual R&D Day on October 27, 2026, to discuss advancements in LB-102, a treatment for schizophrenia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.